JP2005513107A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513107A5
JP2005513107A5 JP2003554211A JP2003554211A JP2005513107A5 JP 2005513107 A5 JP2005513107 A5 JP 2005513107A5 JP 2003554211 A JP2003554211 A JP 2003554211A JP 2003554211 A JP2003554211 A JP 2003554211A JP 2005513107 A5 JP2005513107 A5 JP 2005513107A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
chromium
increase
daily dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003554211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513107A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/041171 external-priority patent/WO2003053454A1/en
Publication of JP2005513107A publication Critical patent/JP2005513107A/ja
Publication of JP2005513107A5 publication Critical patent/JP2005513107A5/ja
Pending legal-status Critical Current

Links

JP2003554211A 2001-12-20 2002-12-20 (−)−ヒドロキシクエン酸、クロム、およびギムネマ酸を含有する組成物、および健常体重を促進する方法と関連する健康因子を改善する方法 Pending JP2005513107A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34347301P 2001-12-20 2001-12-20
PCT/US2002/041171 WO2003053454A1 (en) 2001-12-20 2002-12-20 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors

Publications (2)

Publication Number Publication Date
JP2005513107A JP2005513107A (ja) 2005-05-12
JP2005513107A5 true JP2005513107A5 (enExample) 2008-02-07

Family

ID=23346261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554211A Pending JP2005513107A (ja) 2001-12-20 2002-12-20 (−)−ヒドロキシクエン酸、クロム、およびギムネマ酸を含有する組成物、および健常体重を促進する方法と関連する健康因子を改善する方法

Country Status (10)

Country Link
US (8) US20030119913A1 (enExample)
EP (1) EP1461051A1 (enExample)
JP (1) JP2005513107A (enExample)
AU (1) AU2002364213B2 (enExample)
CA (1) CA2463427A1 (enExample)
IL (1) IL161212A0 (enExample)
MX (1) MXPA04006166A (enExample)
NZ (1) NZ532550A (enExample)
WO (1) WO2003053454A1 (enExample)
ZA (1) ZA200402687B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927636B1 (en) 1997-07-14 2011-04-19 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
US6503905B1 (en) * 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
US20040157929A1 (en) * 2002-04-01 2004-08-12 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating(-)hydroxycitric acid, and related compositions thereof
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US20030119913A1 (en) * 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
DE60313299T2 (de) * 2002-03-01 2008-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Selbstemulgierende systeme zur abgabe von taxoiden
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
JP2004181452A (ja) * 2002-11-30 2004-07-02 Matsushita Electric Ind Co Ltd 洗浄装置、洗浄方法および洗浄剤
TW200427447A (en) * 2003-03-21 2004-12-16 Interhealth Nutraceuticals Inc Method and composition for decreasing ghrelin levels
US20050009919A1 (en) * 2003-07-07 2005-01-13 Clouatre Dallas L. Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20050053555A1 (en) * 2003-07-14 2005-03-10 Crave Busters, Llc. Appetite control compositions and methods of use
US20050215644A1 (en) * 2004-03-19 2005-09-29 Interhealth Nutraceuticals, Inc. Methods for increasing neurotransmitter levels using hydroxycitric acid
WO2005107735A2 (en) 2004-04-30 2005-11-17 Pump Formulations, Ltd. Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a
WO2005107779A2 (en) * 2004-04-30 2005-11-17 New Hc Formulations Ltd. Weight loss composition and method of inducing weight loss
US20060025483A1 (en) * 2004-07-29 2006-02-02 Clouatre Dallas L (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification
EP1799631B1 (en) * 2004-09-24 2017-01-25 Showa Denko K.K. Hydroxycitric acid derivatives and skin external preparations containing the same
AU2005316150A1 (en) * 2004-12-14 2006-06-22 Smartburn Formulations Ltd. Supplement dietary composition for promoting weight loss
US7912716B2 (en) * 2005-10-06 2011-03-22 Sony Online Entertainment Llc Generating words and names using N-grams of phonemes
US20080293815A1 (en) * 2006-10-18 2008-11-27 Glykon Technologies Group, Llc Hca for improved hdl serum lipids profile
US20100323031A1 (en) * 2009-06-22 2010-12-23 Glykon Technologies Group, Llc Synergistic combination to enhance blood glucose and insulin metabolism
US20100323043A1 (en) * 2009-06-23 2010-12-23 Perla Marc D Antimicrobial Compositions and Methods of Making and Using the Same
US9931365B2 (en) 2010-09-28 2018-04-03 Lisa Geng Methods for treating neurological disorders using nutrient compositions
WO2012050895A1 (en) 2010-09-28 2012-04-19 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US20130059035A1 (en) * 2011-09-07 2013-03-07 Massoud Arvanaghi Capsaicin composition and method related thereto
CA3037235A1 (en) 2016-09-22 2018-03-29 Alan B. Cash Method to alleviate the symptoms of pms
CN110882390B (zh) * 2019-11-15 2022-03-15 西安交通大学医学院第一附属医院 人lsm5基因的用途及相关产品
WO2021247289A1 (en) * 2020-06-02 2021-12-09 Glykon Technologies Group, Llc Reducing triglyceride levels and cortisol levels with pharmaceutical preparations

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132219A (en) * 1872-10-15 Improvement in combined knife-sharpeners and glass-cutters
US220329A (en) * 1879-10-07 Improvement in pounder washing-machines
US133992A (en) * 1872-12-17 Improvement in bed-lounges
US14692A (en) * 1856-04-15 Improved diaphragm fluid-meter
US44469A (en) * 1864-09-27 Improved clothes-drier
US3764692A (en) * 1970-09-30 1973-10-09 Hoffmann La Roche Method of treating obesity
US4923855A (en) 1983-07-08 1990-05-08 The William Seroy Group Synthetic GTF chromium material and process therefor
US4954492A (en) * 1983-07-08 1990-09-04 The William Seroy Group Synthetic GTF chromium material for decreasing blood lipid levels and process therefor
US5194615A (en) * 1983-07-08 1993-03-16 The William Seroy Group Synthetic GTF chromium nicotinate material and its preparation
JPS62236469A (ja) * 1986-04-04 1987-10-16 Yasutake Hichi 低カロリ−飲食物
US5266560A (en) * 1988-06-03 1993-11-30 Thomas Research Corporation Pharmaceutical insulin-potentiating CR(III) complexes with GTF-like activity
US5543405A (en) * 1993-10-22 1996-08-06 Keown; Wendy J. Composition and method for weight reduction and long term management of obesity
US5480657A (en) * 1993-10-27 1996-01-02 Allen; Ann De Wees T. Composition comprising caffeine chromium and fructose for weight control and use thereof
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
US5567424A (en) * 1994-06-10 1996-10-22 Reliv International, Inc. Fiber, antioxidant, herbal and enzyme supplemented beverage composition for human consumption
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AU5736096A (en) * 1995-05-15 1996-11-29 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy cit ric acid
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US5716976A (en) * 1996-03-13 1998-02-10 Bernstein; Richard K. Method of treatment for carbohydrate addiction
FI120290B (fi) 1996-12-30 2009-09-15 Mirador Res Oy Ltd Menetelmä, jonka avulla voidaan valmistaa sellaisia mausteseos-, ruoan ainesosa- ja elintarvikekoostumuksia, jotka alentavat seerumin kolesterolia
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5962030A (en) * 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
JP3736776B2 (ja) 1997-03-25 2006-01-18 宝ホールディングス株式会社 新規カルシウム組成物
US5981510A (en) * 1997-04-15 1999-11-09 Yaizu Suisankagaku Industry Co., Ltd. Method for treating and improving diabetes
US5911992A (en) * 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia
US7927636B1 (en) 1997-07-14 2011-04-19 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
US5877171A (en) * 1997-07-28 1999-03-02 Mcleod; Malcolm N. Method of treating pre-menstrual syndrome using chromium
US6160172A (en) * 1997-08-27 2000-12-12 Vittal Mallya Scientific Research Foundation Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties
AU2548899A (en) * 1998-02-23 1999-09-06 Taiyo Kagaku Co. Ltd. Composition comprising theanine
US6048846A (en) * 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6258848B1 (en) * 1998-07-31 2001-07-10 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
US5905075A (en) * 1998-08-28 1999-05-18 Ambi Inc. Chromium nicotinate compositions and uses thereof
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
US6252713B1 (en) * 1998-10-28 2001-06-26 Asahi Kogaku Kogyo Kabushiki Kaisha Optical device provided with correcting function for trembling of focused image
IL144827A0 (en) 1999-02-18 2002-06-30 Vittal Mallya Scient Res Found Soluble double metal salts of hydroxycitric acid, processes for the preparation thereof and beverages containing the same
WO2000057729A2 (en) 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Beverages for treatment of glucose metabolism disorders
US6447807B1 (en) * 1999-09-14 2002-09-10 Dallas L. Clouatre Potassium (-)-hydroxycitric acid methods for pharmaceutical preparations for stable and controlled delivery
US6207714B1 (en) * 1999-09-14 2001-03-27 Dallas L. Clouatre Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid
US20030220329A1 (en) * 1999-09-17 2003-11-27 Duke University Method of improving beta-adrenergic receptor function
IL149907A0 (en) * 1999-12-16 2002-11-10 Mark Nutritionals Inc Nutritional composition, methods of producing said composition and methods of using said composition
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
US7015250B2 (en) * 2000-02-09 2006-03-21 Glykon Technologies Group, Llc Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acid
US6399089B1 (en) * 2000-05-15 2002-06-04 A. Glenn Braswell Compositions and methods for regulating metabolism and balancing body weight
US6383482B1 (en) * 2000-08-24 2002-05-07 Vitacost.Com, Inc. Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus
WO2002024180A2 (en) * 2000-09-21 2002-03-28 Nutrition 21, Inc. Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
US6579866B2 (en) * 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US6420350B1 (en) * 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product
US20020133992A1 (en) * 2001-03-20 2002-09-26 Julie Wu Magnetic display device
IL158172A0 (en) * 2001-03-30 2004-03-28 Interhealth Nutraceuticals Inc Pharmaceutical compositions containing (-)-hydroxycitric acid
US20040157929A1 (en) * 2002-04-01 2004-08-12 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating(-)hydroxycitric acid, and related compositions thereof
US6476071B1 (en) * 2001-05-07 2002-11-05 Dallas L. Clouatre Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acid
US6482858B1 (en) * 2001-06-20 2002-11-19 Dallas L Clouatre (−)-hydroxycitric acid for wound healing and immunomodulation
US6441041B1 (en) * 2001-06-20 2002-08-27 Dallas L. Clouatre (-)-hydroxycitric acid for the prevention of osteoporosis
US6638542B2 (en) * 2001-09-20 2003-10-28 Nutricia N.V. Reducing appetite in mammals by administering procyanidin and hydroxycitric acid
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US20030119913A1 (en) * 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
WO2003092730A1 (en) 2002-04-30 2003-11-13 Unibar Corporation Hydroxycitric acid salt composition and method of making
US6967030B2 (en) * 2003-01-14 2005-11-22 Wright Jonathan V Formulation for insulin and glucose control
TW200427447A (en) * 2003-03-21 2004-12-16 Interhealth Nutraceuticals Inc Method and composition for decreasing ghrelin levels

Similar Documents

Publication Publication Date Title
JP2005513107A5 (enExample)
JP2005508371A5 (enExample)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
IL134271A (en) Pharmaceutical compositions for altering lipids comprising nicotinic acid compounds and hmg-coa reductase inhibitors
JP2004509143A (ja) クロム錯体、共役脂肪酸及び/又は共役脂肪アルコールによる糖尿病の治療、体脂肪減少、インシュリン感受性の改善、高血糖症軽減及び高コレステロール血症軽減の方法及び組成物
JP2011511789A5 (enExample)
JP2008543800A5 (enExample)
HRP20110129T1 (hr) Sastavi koji sadrže kristalni trans-(+/-)-delta-9-tetrahidrokanabinol
JP2008543936A5 (enExample)
JP2009518293A5 (enExample)
CA2453263A1 (en) Pharmaceutical compositions containing terbinafine and use thereof
JP2012236834A5 (enExample)
WO2012009438A2 (en) Anti-appetite adhesive compositions
JP2009517411A5 (enExample)
JP2007238598A5 (enExample)
WO2012090194A2 (en) Compositions and methods for treating a skin disorder
JP2009506978A5 (enExample)
JP2005525329A5 (enExample)
JP2025530301A (ja) 運動障害のための治療用組み合わせ
JP2013540133A5 (enExample)
TW200427447A (en) Method and composition for decreasing ghrelin levels
RU2006137330A (ru) Пероральные матричные композиции, содержащие ликарбазепин
WO2012051107A2 (en) Niacin formulations and methods with reduced flushing side-effect
TWI302457B (en) A pharmaceutical composition for improving blood lipid or reducing blood homocysteine
JP2008543902A5 (enExample)